Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 65

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 65
---
 Rights Agreement also provides such holders with “piggy -back” registration rights, subject to certain requirements and customary conditions. The foregoing description of the Registration Rights Agreement is subject to and qualified in its entirety by reference to the full text of the form of the form Registration Rights Agreement, a copy of which is attached as Exhibit 10.4 to the registration statement of which this proxy statement/prospectus is a part, and the terms of which are incorporated herein by reference. Conflicts of Interests of Certain Persons in the Business Combination There may be actual or potential material conflicts of interest between or among (i) the Sponsor and its affiliates, the NorthView Initial Stockholders, NorthView’s officers or directors, NorthView’s promotors, Profusa’s officers or directors, and (ii) the unaffiliated security holders of NorthView. In addition, I -Bankersand Dawson James, NorthView’s advisors and the managing underwriters of NorthView’s IPO, have a financial interest that may conflict with your interests. In considering the recommendation of NorthView’s Board to vote in favor of Proposal 1 (Business Combination Proposal), NorthView Holders should be aware that, aside from their interests as stockholders, the Sponsor and NorthView’s directors, officers and initial stockholders have interests in the Business Combination that are different from, or in addition to, those of other stockholders and warrant and right holders generally. NorthView’s directors were aware of and considered these interests, among other matters, in evaluating the Business Combination, and in recommending to stockholders that they approve the Business Combination. NorthView Holders should take these interests into account in deciding whether to approve the Business Combination. These interests include, among other things: •The Sponsor beneficially owns 4,743,750 founder shares, which shares would become worthless if NorthView does not complete a business combination within the applicable time period, as such NorthView Initial Stockholders have waived any right to redemption with respect to these shares. The Initial Stockholders paid an aggregate of $25,000 (or $0.005 per share) for 5,175,000 founder shares, 862,500 of which it subsequently forfeited for no consideration. Sponsor subsequently received an additional 431,250 founder shares through a 1.1 -for-1stock dividend. Such shares have an aggregate market value of approximately $57.4million based on the closing price of NorthView Common Stock of $12.10 on May13, 2025, the Record Date